DE60228504D1 - P53 bindende t-zellrezeptormoleküle und deren verwendungen - Google Patents

P53 bindende t-zellrezeptormoleküle und deren verwendungen

Info

Publication number
DE60228504D1
DE60228504D1 DE60228504T DE60228504T DE60228504D1 DE 60228504 D1 DE60228504 D1 DE 60228504D1 DE 60228504 T DE60228504 T DE 60228504T DE 60228504 T DE60228504 T DE 60228504T DE 60228504 D1 DE60228504 D1 DE 60228504D1
Authority
DE
Germany
Prior art keywords
molecules
protein
tcr
cell receptor
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60228504T
Other languages
English (en)
Inventor
Linda A Sherman
Kimberlyn F Card
Jon A Weidanz
Hing C Wong
Elizabeth L Thomson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ImmunityBio Inc
Original Assignee
Altor Bioscience Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altor Bioscience Corp filed Critical Altor Bioscience Corp
Application granted granted Critical
Publication of DE60228504D1 publication Critical patent/DE60228504D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE60228504T 2001-06-05 2002-06-05 P53 bindende t-zellrezeptormoleküle und deren verwendungen Expired - Lifetime DE60228504D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29632401P 2001-06-05 2001-06-05
PCT/US2002/017785 WO2004018619A2 (en) 2001-06-05 2002-06-05 P53 binding t cell receptor molecules and uses thereof

Publications (1)

Publication Number Publication Date
DE60228504D1 true DE60228504D1 (de) 2008-10-02

Family

ID=31946570

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60228504T Expired - Lifetime DE60228504D1 (de) 2001-06-05 2002-06-05 P53 bindende t-zellrezeptormoleküle und deren verwendungen

Country Status (11)

Country Link
US (1) US7456263B2 (de)
EP (2) EP2009019A1 (de)
JP (1) JP4447456B2 (de)
CN (1) CN1692124B (de)
AT (1) ATE405582T1 (de)
AU (1) AU2002316190B8 (de)
CA (1) CA2487779C (de)
DE (1) DE60228504D1 (de)
DK (1) DK1546188T3 (de)
ES (1) ES2307770T3 (de)
WO (1) WO2004018619A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001093913A2 (en) * 2000-06-05 2001-12-13 Sunol Molecular Corporation T cell receptor fusions and conjugates and methods of use thereof
KR101131297B1 (ko) 2003-11-10 2012-03-30 알토 바이오사이언스 코포레이션 가용성 티씨알 분자 및 이용 방법
US7994298B2 (en) 2004-09-24 2011-08-09 Trustees Of Dartmouth College Chimeric NK receptor and methods for treating cancer
CA2777053A1 (en) 2009-10-06 2011-04-14 The Board Of Trustees Of The University Of Illinois Human single-chain t cell receptors
US9273283B2 (en) 2009-10-29 2016-03-01 The Trustees Of Dartmouth College Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
WO2011059836A2 (en) 2009-10-29 2011-05-19 Trustees Of Dartmouth College T cell receptor-deficient t cell compositions
US9833476B2 (en) 2011-08-31 2017-12-05 The Trustees Of Dartmouth College NKP30 receptor targeted therapeutics
JP6389166B2 (ja) 2012-05-07 2018-09-12 トラスティーズ・オブ・ダートマス・カレッジ 抗ｂ７−ｈ６抗体、融合タンパク質、及びこれらを使用する方法
UA114108C2 (uk) 2012-07-10 2017-04-25 Борд Оф Ріджентс, Дзе Юніверсіті Оф Техас Сістем Моноклональне антитіло для застосування в діагностиці і терапії злоякісних пухлин і аутоімунного захворювання
AU2018342246A1 (en) * 2017-09-29 2020-04-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services T cell receptors recognizing mutated p53
KR20200063215A (ko) 2017-10-06 2020-06-04 오슬로 유니버시테시케후스 에이치에프 키메라 항원 수용체
CN108060135A (zh) * 2017-12-26 2018-05-22 东莞赛尔生物科技有限公司 一种高效表达p53抑癌蛋白的t细胞、制备方法及应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4867973A (en) * 1984-08-31 1989-09-19 Cytogen Corporation Antibody-therapeutic agent conjugates
US5057313A (en) * 1986-02-25 1991-10-15 The Center For Molecular Medicine And Immunology Diagnostic and therapeutic antibody conjugates
WO1988007553A1 (en) * 1987-03-26 1988-10-06 Teijin Limited Process for preparing antibody complex
EP0515527A4 (en) * 1990-02-20 1993-08-25 Coulter Corporation Improved antibody-enzyme direct conjugates and method of making same
GB9200417D0 (en) * 1992-01-09 1992-02-26 Bagshawe Kenneth D Cytotoxic drug therapy
US6399368B1 (en) * 1992-01-17 2002-06-04 Board Of Regents, The University Of Texas System Secretion of T cell receptor fragments from recombinant Escherichia coli cells
US5679641A (en) * 1992-05-26 1997-10-21 Rijksuniversiteit Leiden Peptides of human P53 protein for use in human T cell response inducing compositions, and human P53 protein-specific cytotoxic t-lymphocytes
WO1994012520A1 (en) * 1992-11-20 1994-06-09 Enzon, Inc. Linker for linked fusion polypeptides
DE69519101T3 (de) 1994-07-29 2010-08-05 Sunol Molecular Corp., Miramar Mhc-komplexe und ihre verwendung
WO1996013593A2 (en) 1994-10-26 1996-05-09 Procept, Inc. Soluble single chain t cell receptors
AU712441B2 (en) 1994-12-14 1999-11-04 Scripps Research Institute, The In vivo activation of tumor-specific cytotoxic T cells
US5830755A (en) * 1995-03-27 1998-11-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services T-cell receptors and their use in therapeutic and diagnostic methods
US5869270A (en) 1996-01-31 1999-02-09 Sunol Molecular Corporation Single chain MHC complexes and uses thereof
CA2246333A1 (en) 1996-03-05 1997-09-12 The Scripps Research Institute Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens
US6127524A (en) 1996-10-18 2000-10-03 Dade Behring Inc. Binding molecules and computer-based methods of increasing the binding affinity thereof
EP0977886A4 (de) 1997-03-07 2002-10-23 Sunol Molecular Corp Fusionsproteine, welche ein bakteriophagen-hüllprotein sowie einen einzelketten t-zell-rezeptor enthalten
KR100712256B1 (ko) 1997-10-02 2007-04-27 알토 바이오사이언스 코포레이션 가용성 단일쇄 ｔ-세포 수용체 단백질
JP4467188B2 (ja) 1998-10-21 2010-05-26 アルター・バイオサイエンス・コーポレーション 多重特異的結合分子とその使用
JP2004501364A (ja) 2000-05-25 2004-01-15 スノル・モレキュラー・コーポレーション Ｔ−細胞レセプター相互作用のモジュレーション
WO2001093913A2 (en) 2000-06-05 2001-12-13 Sunol Molecular Corporation T cell receptor fusions and conjugates and methods of use thereof
DE10109855A1 (de) 2001-03-01 2002-09-12 Stanislawski Thomas Polypeptide eines p53-Protein-spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung

Also Published As

Publication number Publication date
CA2487779C (en) 2012-10-02
AU2002316190A1 (en) 2004-03-17
CA2487779A1 (en) 2004-03-04
CN1692124A (zh) 2005-11-02
ES2307770T3 (es) 2008-12-01
JP2005525128A (ja) 2005-08-25
JP4447456B2 (ja) 2010-04-07
US7456263B2 (en) 2008-11-25
EP2009019A1 (de) 2008-12-31
EP1546188B1 (de) 2008-08-20
WO2004018619A3 (en) 2005-05-06
CN1692124B (zh) 2012-05-30
EP1546188A4 (de) 2005-12-21
AU2002316190B8 (en) 2009-01-29
US20080269113A1 (en) 2008-10-30
EP1546188A2 (de) 2005-06-29
DK1546188T3 (da) 2008-10-27
AU2002316190B2 (en) 2009-01-22
AU2002316190A8 (en) 2004-04-08
ATE405582T1 (de) 2008-09-15
WO2004018619A2 (en) 2004-03-04

Similar Documents

Publication Publication Date Title
DK1124568T3 (da) Polyspecifikke bindingsmolekyler og anvendelser deraf
DE60228504D1 (de) P53 bindende t-zellrezeptormoleküle und deren verwendungen
ATE454159T1 (de) Von survivin abgeleitete peptide und deren verwendung
DE69730693D1 (de) Mhc-komplexe und ihre verwendungen
ATE533784T1 (de) Lösliche, einzelkettige proteine des t- zellrezeptors
CY1108083T1 (el) Αντιγονα και συνθεσεις του neisseria meningitidis
GB2339430A8 (en) Method for the production of non-immunogenic proteins
NO20053304D0 (no) NOGO A bindingsmolekyler og farmasoytisk anvendelse av disse.
DK0643726T3 (da) Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei
CY1107881T1 (el) Τροποποιημενα πεπτιδια ως θεραπευτικοι παραγοντες
CY1106070T1 (el) Πολυμορφισμοι στο γονιδιο c μεταφορας οργανικου ανιοντος ανθρωπου (oatp-c) - (organic anion transporter c gene)
DE69931482D1 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
HUP0301812A2 (hu) Átvizsgálási (screening) eljárás
ATE336579T1 (de) Isolierte mhc-klasse ii-bindende peptide, und deren verwendung
WO2001029220A3 (en) Mage-a12 antigenic peptides and uses thereof
MXPA02005236A (es) Metodos de tratamiento de lupus con base en la afinidad de anticuerpos y metodos de separacion por exclusion y composiciones para el uso de los mismos.
CA2270877A1 (en) Peptide-based immunotherapeutic agent
WO2003104259A3 (en) PEPTIDES PRESENTED BY HLA-B18 AND HLA-CW16 MOLECULES AND USES OF SUCH PEPTIDES

Legal Events

Date Code Title Description
8364 No opposition during term of opposition